Sibutramine
Therapeutic agent (verify pharmacological class)
What it is used for
As a short-term (8-12 weeks) adjunct in a course of weight reduction based on diet restriction. Clinical selection for Sibutramine should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Tachycardia; hypertension; head- ache; light headedness; worsening of haemor- rhoids; insomnia; dry mouth; paraesthesia; sweat- ing; taste disorders; constipation; vasodilation.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.